333 related articles for article (PubMed ID: 16533773)
21. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
Wang HC; Chou WC; Shieh SY; Shen CY
Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
[TBL] [Abstract][Full Text] [Related]
22. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
Qi Y; Schoene NW; Lartey FM; Cheng WH
J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
[TBL] [Abstract][Full Text] [Related]
23. Ku, Artemis, and ataxia-telangiectasia-mutated: signalling networks in DNA damage.
Morio T; Kim H
Int J Biochem Cell Biol; 2008; 40(4):598-603. PubMed ID: 18243767
[TBL] [Abstract][Full Text] [Related]
24. The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.
Laporte GA; Leguisamo NM; Gloria HCE; Azambuja DB; Kalil AN; Saffi J
J Surg Oncol; 2020 Apr; 121(5):906-916. PubMed ID: 31650563
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Ku70 protein expression in patients with advanced colorectal cancer.
Komuro Y; Watanabe T; Hosoi Y; Matsumoto Y; Nakagawa K; Suzuki N; Nagawa H
Hepatogastroenterology; 2005; 52(64):995-8. PubMed ID: 16001615
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.
Honrado E; Osorio A; Palacios J; Milne RL; Sánchez L; Díez O; Cazorla A; Syrjakoski K; Huntsman D; Heikkilä P; Lerma E; Kallioniemi A; Rivas C; Foulkes WD; Nevanlinna H; Benítez J
J Clin Oncol; 2005 Oct; 23(30):7503-11. PubMed ID: 16234517
[TBL] [Abstract][Full Text] [Related]
27. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
[TBL] [Abstract][Full Text] [Related]
29. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation.
Xue L; Yu D; Furusawa Y; Okayasu R; Tong J; Cao J; Fan S
Mutat Res; 2009 Nov; 670(1-2):15-23. PubMed ID: 19583974
[TBL] [Abstract][Full Text] [Related]
30. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.
Losi L; Ponti G; Gregorio CD; Marino M; Rossi G; Pedroni M; Benatti P; Roncucci L; de Leon MP
Pathol Res Pract; 2006; 202(9):663-70. PubMed ID: 16860493
[TBL] [Abstract][Full Text] [Related]
32. Human MutL-complexes monitor homologous recombination independently of mismatch repair.
Siehler SY; Schrauder M; Gerischer U; Cantor S; Marra G; Wiesmüller L
DNA Repair (Amst); 2009 Feb; 8(2):242-52. PubMed ID: 19022408
[TBL] [Abstract][Full Text] [Related]
33. Genetic steps of mammalian homologous repair with distinct mutagenic consequences.
Stark JM; Pierce AJ; Oh J; Pastink A; Jasin M
Mol Cell Biol; 2004 Nov; 24(21):9305-16. PubMed ID: 15485900
[TBL] [Abstract][Full Text] [Related]
34. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified.
Ward RL; Turner J; Williams R; Pekarsky B; Packham D; Velickovic M; Meagher A; O'Connor T; Hawkins NJ
J Pathol; 2005 Dec; 207(4):377-84. PubMed ID: 16175654
[TBL] [Abstract][Full Text] [Related]
35. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
[TBL] [Abstract][Full Text] [Related]
36. Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions.
Tomimatsu N; Mukherjee B; Deland K; Kurimasa A; Bolderson E; Khanna KK; Burma S
DNA Repair (Amst); 2012 Apr; 11(4):441-8. PubMed ID: 22326273
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer.
Hosoi Y; Watanabe T; Nakagawa K; Matsumoto Y; Enomoto A; Morita A; Nagawa H; Suzuki N
Int J Oncol; 2004 Aug; 25(2):461-8. PubMed ID: 15254745
[TBL] [Abstract][Full Text] [Related]
38. ATM activation by ionizing radiation requires BRCA1-associated BAAT1.
Aglipay JA; Martin SA; Tawara H; Lee SW; Ouchi T
J Biol Chem; 2006 Apr; 281(14):9710-8. PubMed ID: 16452482
[TBL] [Abstract][Full Text] [Related]
39. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade.
Ding SL; Sheu LF; Yu JC; Yang TL; Chen BF; Leu FJ; Shen CY
Br J Cancer; 2004 May; 90(10):1995-2001. PubMed ID: 15138484
[TBL] [Abstract][Full Text] [Related]
40. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
